BNP Paribas Exane on Crocs (CROX): 'We believe results and guidance for the Crocs brand were generally in-line with expectation'

Go back to BNP Paribas Exane on Crocs (CROX): 'We believe results and guidance for the Crocs brand were generally in-line with expectation'

Crocs (CROX) PT Lowered to $138 at Stifel, 'Brand and Improving Balance Sheet Support Risk/Reward'

October 30, 2024 7:00 AM EDT

Stifel analyst Jim Duffy lowered the price target on Crocs (NASDAQ: CROX) to $138.00 (from $158.00) while maintaining a Buy rating.

The analyst comments "3Q24 revenue (+$16mn) and adj. EPS upside (+$0.52) benefited from a pull-forward of wholesale orders, and 4Q24 revenue and adj.... More

Raymond James Downgrades Crocs (CROX) to Market Perform

October 30, 2024 6:25 AM EDT

Raymond James analyst Rick Patel downgraded Crocs (NASDAQ: CROX) from Outperform to Market Perform.


For an analyst ratings summary and ratings history on Crocs click here. For more ratings news on Crocs click here.


Shares of Crocs closed at $111.58 yesterday.

... More

Crocs (CROX) PT Lowered to $150 at KeyBanc

October 30, 2024 2:22 AM EDT

KeyBanc analyst Ashley Owens lowered the price target on Crocs (NASDAQ: CROX) to $150.00 (from $155.00) while maintaining a Overweight rating.... More

Crocs (CROX) PT Lowered to $125 at Barclays

October 29, 2024 2:36 PM EDT

Barclays analyst Adrienne Yih lowered the price target on Crocs (NASDAQ: CROX) to $125.00 (from $164.00) while maintaining a Overweight rating.

The analyst comments "3Q24 results beat expectations on sales, OM, and EPS, mostly driven by SG&A leverage. Despite the... More

Crocs (CROX) PT Lowered to $140 at Williams Trading

October 29, 2024 2:21 PM EDT

Williams Trading analyst Sam Poser lowered the price target on Crocs (NASDAQ: CROX) to $140.00 (from $163.00) while maintaining a Buy rating.

The analyst comments "Lowering PT from $163 to $140, raising FY24 estimates, lowering FY25 estimates, and introducing FY26 estimates. The better than expected 3Q24 results were driven by a 7.5% increase in Crocs revenue, which beat consensus by 2.5%,... More

Crocs shares slide after shoe retailer tempers full-year sales outlook

October 29, 2024 7:49 AM EDT

Investing.com -- Shares in Crocs (NASDAQ: CROX) sank in premarket US trading on Tuesday after the shoe seller tempered its full-year revenue guidance due to weakness at its Hey Dude casual footwear brand.


Crocs said it now expects to report annual revenue... More

Crocs (CROX) Tops Q3 EPS by 50c; offers guidance

October 29, 2024 7:02 AM EDT

Crocs (NASDAQ: CROX) reported Q3 EPS of $3.60, $0.50 better than the analyst estimate of $3.10. Revenue for the quarter came in at $1.06 billion versus the consensus estimate of $1.05 billion.

GUIDANCE:

Crocs sees Q4 2024 EPS of $2.20-$2.28, versus the consensus of... More